Indegene files draft papers with Sebi; eyes Rs 3,200 crore via IPO

The IPO comprises a fresh issue of equity shares worth up to Rs 950 crore and an Offer For Sale (OFS) of up to 3.63 crore equity shares by existing investors, according to the DRHP

Indegene, a healthcare tech firm focused on the global life sciences industry, has filed preliminary papers with capital markets regulator Securities and Exchange Board of India (Sebi) to raise as much as Rs 3,200 crore through an initial public offering (IPO).

The IPO comprises a fresh issue of equity shares worth up to Rs 950 crore and an Offer For Sale (OFS) of up to 3.63 crore equity shares by existing investors, according to the Draft Red Herring Prospectus (DRHP).

The OFS consists of up to 27 lakh equity shares to be sold by individual selling shareholders — Manish Gupta, Rajesh Bhaskaran